2017
RAISED FUNDS
RS Researched raised a total of 2 million Euros from technology focused venture capital fund ACT Venture Partners.
2020
CLINICAL TRIALS
As a result of promising results from pre-clinical studies, RS Research started preparations for phase-1 clinical trials.
